Boston Research & Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$582K |
| 2 |
iShares Biotechnology ETF
IBB
|
+$530K |
| 3 |
Texas Instruments
TXN
|
+$201K |
| 4 |
Verizon
VZ
|
+$93.4K |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$34.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Biotech ETF
BBH
|
+$623K |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$600K |
| 3 |
GE Aerospace
GE
|
+$573K |
| 4 |
Microsoft
MSFT
|
+$445K |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$433K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.54% |
| 2 | Technology | 13.69% |
| 3 | Financials | 12.39% |
| 4 | Healthcare | 11.03% |
| 5 | Consumer Staples | 10.05% |
Similar funds
Boston Research & Management's Q4 2017 Portfolio in Review
As of Q4 2017, Boston Research & Management held 98 positions worth $199M, up 1.9% from $196M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Boston Research & Management withdrew a net $8.84M in Q4 2017, closing 1 position and reducing 64 holdings. Its most notable exit was State Street Energy Select Sector SPDR ETF, an estimated $433K position sold in full.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Boston Research & Management opened a new position in iShares Biotechnology ETF worth $529K.
- Boston Research & Management's largest Q4 2017 buy was iShares Biotechnology ETF: 4,959 shares worth $529K.
- Boston Research & Management added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $582K increase.
- Boston Research & Management's biggest Q4 2017 reduction was VanEck Biotech ETF, cutting an estimated $623K.
- Boston Research & Management fully exited State Street Energy Select Sector SPDR ETF in Q4 2017, selling an estimated $433K.
- Boston Research & Management's ten largest holdings make up 24% of its $199M portfolio in Q4 2017.
- Boston Research & Management opened 2 new positions and closed 1 in Q4 2017.
- Boston Research & Management's portfolio value rose 1.9% quarter-over-quarter to $199M.
Based on Boston Research & Management's 13F filing for Q4 2017, filed 9 Feb 2018.